Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Phase 1
Active, not recruiting
- Conditions
- Osteoarthritis, KneeOsteo Arthritis KneeKnee Osteoarthritis
- Interventions
- Genetic: GNSC-001Drug: PlaceboDrug: transient immune-modulation
- First Posted Date
- 2023-04-28
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Genascence Corporation
- Target Recruit Count
- 67
- Registration Number
- NCT05835895
- Locations
- 🇺🇸
Well Pharma Medical Research, Miami, Florida, United States
🇺🇸South Florida Research, Miami Springs, Florida, United States
🇺🇸Premier Medical Associates, The Villages, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath